Control message

BEHAVIORAL6 trials

Sponsors

Emory University, Yale University, Masonic Cancer Center, University of Minnesota, Georgia State University, Stanford University

Conditions

COVID-19Childhood VaccinationsCigaretteCigarette UseHuman PapillomavirusScreen Time ExposureSmokingSmoking Behavior

Early Phase 1

Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices

CompletedNCT04740008

Masonic Cancer Center, University of MinnesotaCigarette, Smoking

Start: 2021-04-20End: 2022-08-24Updated: 2024-02-26

Unknown Phase

Tailoring of Vaccine-Focused Messages: Moral Foundations

CompletedNCT02851459

Emory UniversityChildhood Vaccinations

Start: 2016-08-31End: 2016-10-31Updated: 2017-03-10

Tailoring of Vaccine-Focused Messages: Disease Salience

CompletedNCT03002324

Emory UniversityHuman Papillomavirus

Start: 2017-01-31End: 2017-05-01Updated: 2017-05-10

COVID-19 Vaccine Messaging, Part 1

CompletedNCT04460703

Yale UniversityCOVID-19, Vaccination

Start: 2020-07-03End: 2020-07-08Updated: 2022-05-05

Communicating About Nicotine Reduction in Cigarettes

RecruitingNCT06787937

Georgia State UniversityCigarette Use, Smoking Behavior, Tobacco Products

Start: 2025-09-11End: 2029-01-31Target: 1230Updated: 2025-10-29

Reactions to Social Media Warning Labels Among Teens and Young Adults

CompletedNCT07199660

Stanford UniversityScreen Time Exposure

Start: 2025-12-02End: 2025-12-16Updated: 2026-03-16

Related Papers

Nicotine Intervention and Communication for Empowering Reduction (NICER): study protocol for a randomized controlled trial among priority populations of people who smoke.

2025-11-17

Persuasive messaging to increase COVID-19 vaccine uptake intentions.

2021-10-2253 citations

Cancer-salient messaging for Human Papillomavirus vaccine uptake: A randomized controlled trial.

2018-03-2614 citations